Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseThe goal of this observational study is to valuate the sensitivity and specificity of different blood biomarkers for monitoring and assessing Aβ-PET-confirmed mitigation of amyloid pathology by lencanumab treatment in subjects treated with lencanumab. Alzheimer À vérifier À vérifier China À vérifier
An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseThe goal of this observational study is to valuate the sensitivity and specificity of different blood biomarkers for monitoring and assessing Aβ-PET-confirmed mitigation of amyloid pathology by lencanumab treatment in subjects treated with lencanumab. Alzheimer À vérifier À vérifier China À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease Alzheimer À vérifier NCT07153848 An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.